Hemagglutination inhibition test
The hemagglutination inhibition test (HHT, HAHT, also Hirst test) is based on the fact that the blood-clotting ( hemagglutinating ) effect of some viruses is inhibited by antibodies that bind to the hemagglutinating virus components.
Antigens with hemagglutinating properties occur, for example, in the influenza virus (due to the hemagglutinin ) and rubella virus . If a patient's serum can prevent hemagglutination by a virus, this is an indication that the patient has developed specific antibodies when infected with such a virus.
The HHT titer (also HAHT titer) is the reciprocal value of the highest serum dilution at which hemagglutination is still prevented.